Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan Open-Label Extension for Autism
NCT00943579Phase 3Completed
- Sponsor
- Children's Health Council
- Start
- Aug 2009
- Primary completion
- Dec 2011
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sapropterin in Autism Spectrum Disorder (ASD), sponsored by Children's Health Council. Started Aug 2009; status: completed.
02
Drugs
sapropterin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00943579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943579.